Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

8.170 +0.350 (+4.48%)

Official Closing Price Updated: 7:00 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Dyadic Intl. Inc. (NASDAQ: DYAI) Potential Strategic Alliances with Future of Foods Boosts Stock as Key Conference Looms

March 19, 2024

Via AB Newswire

Topics Supply Chain

Is Ginkgo Bioworks Stock a Buy? ↗

March 15, 2024

There's a lot to like about this business, but it's still a risky bet.

Via The Motley Fool

3 Pharmaceutical Stocks to Buy Hand Over Fist in March ↗

March 11, 2024

There are some great companies at attractive prices in the lucrative pharmaceutical space.

Via The Motley Fool

Is Ginkgo Bioworks Destined to Be in a "Magnificent Seven" of Healthcare Stocks? ↗

March 03, 2024

It isn't ready for membership today, but it could have a path in the future.

Via The Motley Fool

S&P 500, Nasdaq 100 Hit Record Highs As Dollar, Treasury Yields Weaken, Chipmakers Shine, NYCB Sinks: What's Driving Markets Friday? ↗

March 01, 2024

March began on a high note on Wall Street, with tech stocks driving indices to record levels. Despite weak data and mixed Fed remarks, investors remain optimistic. Semiconductor industry continues to...

Via Benzinga

Topics Economy Stocks

Why Ginkgo Bioworks Stock Is Sinking Today ↗

March 01, 2024

There wasn't much to like in Ginkgo's Q4 update.

Via The Motley Fool

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 01, 2024

Shares of Zscaler, Inc. (NASDAQ: ZS) shares fell sharply during Friday’s session following second-quarter results.

Via Benzinga

Why Ginkgo Bioworks Stock Is Down After Earnings ↗

March 01, 2024

Ginkgo said the decrease in sales was primarily driven by the expected ramp down of K-12 testing in Ginkgo's Biosecurity segment and the impact of Cell Engineering downstream value share from equity...

Via Benzinga

Hewlett Packard Enterprise Posts Mixed Q1 Results, Joins Fisker, Plug Power And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

March 01, 2024

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 100 points on Friday.

Via Benzinga

Topics Stocks

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

Earnings Outlook For Ginkgo Bioworks Holdings ↗

February 28, 2024

Via Benzinga

Is Ginkgo Bioworks Stock a Buy Now? ↗

February 24, 2024

Ginkgo Bioworks says it is experiencing strong growth from its biopharma customers.

Via The Motley Fool

bit.bio Announced as Inaugural Partner of Ginkgo Bioworks’ New Technology Network

February 28, 2024

From bit.bio

Via Business Wire

2 Top Biotech Stocks That Wall Street Thinks Could Soon Double in Value ↗

February 23, 2024

These two businesses have viable paths to making investors richer -- possibly soon.

Via The Motley Fool

7 Stocks Cathie Wood Is Still Loading Up On in Q1 ↗

February 13, 2024

You won't find many timid bets among the Cathie Wood stocks she believes will dramatically alter our future.

Via InvestorPlace

2 Cathie Wood Stocks With Jaw-Dropping Growth Potential ↗

February 08, 2024

These two platform biotechs could revolutionize the field of biologically based products.

Via The Motley Fool

Cathie Wood Just Bought These 3 Biotech Stocks. Should You? ↗

February 07, 2024

They aren't all long shots, but they're all innovative.

Via The Motley Fool

Evaluating Ginkgo Bioworks Holdings: Insights From 4 Financial Analysts ↗

January 23, 2024

Via Benzinga

Not Shy Of Buying The Dip, Cathie Wood's Ark Mops Up Over $11M Worth Of Shares In Tesla — Sells Nvidia Stock ↗

February 05, 2024

Via Benzinga

Cathie Wood's Ark Loads Up On $3.3M Worth Of Robinhood Shares, Continues Its Tesla Stock Purchase Spree ↗

January 31, 2024

Via Benzinga

Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought Last Week ↗

January 28, 2024

Wood added to her existing positions in these three exciting companies.

Via The Motley Fool

2 Growth Stocks That Could Rocket 144% and 202% Higher This Year, According to Wall Street ↗

January 27, 2024

Expectations for these stocks are sky-high, but so are the risks.

Via The Motley Fool

3 Healthcare Stocks at 52-Week Lows: Buy or Bye? ↗

January 26, 2024

Investors should consider picking up these healthcare stocks at 52-week lows to benefit from their potential rebound.

Via InvestorPlace

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought This Week ↗

January 25, 2024

The widely followed growth stock investor is adding to some of her holdings this week.

Via The Motley Fool

NuStar Energy, Spirit Airlines, Fastly And Other Big Stocks Moving Higher On Monday ↗

January 22, 2024

U.S. stocks traded higher, with the Dow Jones index gaining around 200 points on Monday. Shares of NuStar Energy L.P. (NYSE: NS) rose sharply during Monday’s session after Sunoco announced it will...

Via Benzinga

Topics Stocks

Cathie Wood's Ark Invest Sells $8.04M Worth of DraftKings Shares ↗

January 17, 2024

Via Benzinga

3 Pricey Stocks I'll Be Watching Like a Hawk in 2024 ↗

January 14, 2024

Good things come to those who wait.

Via The Motley Fool

Flexsteel Industries Posts Strong Preliminary Results, Joins Wipro, Sify Technologies And Other Big Stocks Moving Higher In Friday's Pre-Market Session ↗

January 12, 2024

U.S. stock futures were mixed this morning, with the Dow futures gaining around 50 points on Friday.

Via Benzinga

Topics Stocks

Analyst Assesses Cell-Programming Focused Ginkgo Bioworks' Positioning Amid Revenue Surge, Program Adjustments ↗

January 10, 2024

Wednesday, Ginkgo Bioworks Holdings Inc (NYSE: DNA) released preliminary FY23 sales of $250 million-$260 million, compared to the consensus of $258.65 million.

Via Benzinga

3 Cathie Wood Stocks to Start Off Your New Year Right ↗

January 10, 2024

The following stocks could deliver big gains over time.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

All News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Starting at $3.75/week.

Subscribe Today